{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:29:18Z","timestamp":1793046558097,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejso.2026.111857","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:44:43Z","timestamp":1777941883000},"page":"111857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative survival in gastric cancer: Mucosa-confined with extensive nodal metastases versus serosal invasion without nodal spread"],"prefix":"10.1016","volume":"52","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.111857_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10251","key":"10.1016\/j.ejso.2026.111857_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejso.2026.111857_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2026.111857_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijrobp.2005.05.005","article-title":"An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach","volume":"63","author":"Kim","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.ejso.2026.111857_bib6","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"issue":"9813","key":"10.1016\/j.ejso.2026.111857_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial","volume":"379","author":"Bang","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.ejso.2026.111857_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2011.39.1953","article-title":"Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial","volume":"30","author":"Lee","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111857_bib10","series-title":"TNM classification of malignant tumours","year":"2025"},{"key":"10.1016\/j.ejso.2026.111857_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.suronc.2019.03.005","article-title":"A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA","volume":"29","author":"Chen","year":"2019","journal-title":"Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111857_bib12","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1245\/s10434-019-07221-1","article-title":"The relevance of serosal exposure without nodal metastasis in resectional gastric cancer","volume":"26","author":"Jung","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111857_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17474124.2021.1845140","article-title":"A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors","volume":"15","author":"Yang","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111857_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jjco\/hyg042","article-title":"Clinicopathological analysis for recurrence of early gastric cancer","volume":"33","author":"Lee","year":"2003","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111857_bib15","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00423-021-02231-8","article-title":"High frequency of bone recurrence as an initial recurrence site after radical surgery in T1N3 gastric cancer: a propensity score matching analysis","volume":"406","author":"Tsutsumi","year":"2021","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12876-023-02915-z","article-title":"Novel nomogram to predict the overall survival of postoperative patients with gastric signet","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12957-025-03978-w","article-title":"Evaluation of different lymph node classification systems as independent prognosticators in gastric signet ring cell carcinoma","volume":"23","author":"Wang","year":"2025","journal-title":"World J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111857_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.surg.2015.11.002","article-title":"Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection","volume":"159","author":"Lee","year":"2016","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000064417","article-title":"Prognosis of patients with T2N0 tumors in the alimentary tract: should they be considered as early cancers?","volume":"66","author":"Tachibana","year":"2002","journal-title":"Digestion"},{"issue":"8","key":"10.1016\/j.ejso.2026.111857_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/pin.12306","article-title":"The development of the TNM classification of gastric cancer","volume":"65","author":"Wittekind","year":"2015","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s12672-025-02865-w","article-title":"Clinicopathological features and prognostic significance of site-specific metastasis in gastric cancer: a population-based, propensity score-matched analysis","volume":"16","author":"Huang","year":"2025","journal-title":"Discov Oncol"},{"issue":"17","key":"10.1016\/j.ejso.2026.111857_bib22","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i17.5104","article-title":"TNM staging of colorectal cancer should be reconsidered by T stage weighting","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3796-1","article-title":"A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database","volume":"18","author":"Kong","year":"2018","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.ejso.2026.111857_bib24","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1002\/cncr.35491","article-title":"The prognostic impact of tumor deposits in colorectal cancer: more than just N1c","volume":"130","author":"Bhutiani","year":"2024","journal-title":"Cancer"},{"issue":"26","key":"10.1016\/j.ejso.2026.111857_bib26","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41388-022-02350-6","article-title":"Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets","volume":"41","author":"Puccini","year":"2022","journal-title":"Oncogene"},{"issue":"40","key":"10.1016\/j.ejso.2026.111857_bib27","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","article-title":"Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge","volume":"21","author":"Pernot","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111857_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/SLA.0b013e3181b21c7b","article-title":"Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation","volume":"250","author":"Piessen","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib29","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1038\/s41467-023-38426-4","article-title":"Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features","volume":"14","author":"Zhao","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ejso.2026.111857_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/01635581.2020.1749290","article-title":"Modified Glasgow prognostic score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in metastatic gastric cancer","volume":"73","author":"Demirelli","year":"2021","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ejso.2026.111857_bib31","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18659","article-title":"Prognostic value of inflammatory and nutritional indexes among patients with unresectable advanced gastric cancer receiving immune checkpoint inhibitors combined with chemotherapy-a retrospective study","volume":"12","author":"Zhu","year":"2024","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.ejso.2026.111857_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5230\/jgc.2021.21.e22","article-title":"Prognostic value of the anatomic region of metastatic lymph nodes in the current TNM staging of gastric cancer","volume":"21","author":"Jeong","year":"2021","journal-title":"J Gastric Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib33","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1186\/s12885-023-11653-0","article-title":"Refining gastric cancer staging: examining the interplay between number and anatomical location of metastatic lymph nodes - a retrospective multi-institutional study","volume":"23","author":"Jeon","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.111857_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jso.10228","article-title":"Metastatic pattern of lymph node and surgery for gastric stump cancer","volume":"82","author":"Han","year":"2003","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00432-011-1034-9","article-title":"The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer","volume":"138","author":"Li","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111857_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12880-021-00587-3","article-title":"Integrating No.3 lymph nodes and primary tumor radiomics to predict lymph node metastasis in T1-2 gastric cancer","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Med Imag"},{"issue":"1059","key":"10.1016\/j.ejso.2026.111857_bib37","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150758","article-title":"Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection--do N3 patients benefit from additional radiation?","volume":"89","author":"Fan","year":"2016","journal-title":"Br J Radiol"},{"issue":"25","key":"10.1016\/j.ejso.2026.111857_bib38","first-page":"S0360","article-title":"Long-term prognostic analysis of chemoradiation therapy versus chemotherapy after D2 resection for high-risk gastric cancer: results from a prospective randomized control study","author":"Qiao","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:46:25Z","timestamp":1781333185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0748798326004762"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111857","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative survival in gastric cancer: Mucosa-confined with extensive nodal metastases versus serosal invasion without nodal spread","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111857"}}